PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Novozymes Biopharma Unveils New Online Customer Experience - Novozymes Biopharma, part of Novozymes A/S, world leader in bio-innovation, today unveils its new website
Novozymes Biopharma Unveils New Online Customer Experience


NewswireToday - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2009/08/18 - Novozymes Biopharma, part of Novozymes A/S, world leader in bio-innovation, today unveils its new website.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


The new website has been designed to enhance usability and provide a comprehensive resource for information on Novozymes Biopharma's innovative range of products and technologies. Novozymes Biopharma specializes in recombinant products and technologies for the biopharmaceutical industry helping customers improve drug safety and efficacy.

Building on its established pedigree and reputation in the pharmaceutical and biotechnology industries, the new easy to navigate website provides visitors with quick and easy access to a wealth of information about customer solutions to optimize biopharmaceutical manufacturing, improve drug products and contribute to better lives for patients. The site incorporates the latest company news and events, and in-depth resource sections offering downloadable brochures, application notes and data sheets on all Novozymes Biopharma's animal-free products and technologies. Visitors can also use the website to view specialist articles and presentations from key company representatives covering a number of interesting industry topics.

Novozymes Biopharma is committed to creating an open dialog and developing lasting partnerships throughout the biopharmaceutical industry. To reflect this, the new website has enhanced its customer interaction facilities and allows customers to request meetings and product samples. Further information can also be requested on any product or application at the touch of a button.

Visitors to the new website have the opportunity to win an Apple MacBook Air during the first month of the launch. By completing a two minute online entry form participants will be entered into this special prize draw and the winner will be notified by email.

Peter Rosholm, Vice President at Novozymes Biopharma, said: "We are delighted to announce the launch of our new website. Novozymes is committed to keeping its customers ahead of industry challenges and developing tailored solutions to deliver continued commercial success. This new website provides a comprehensive resource for both current customers and organizations interested in how Novozymes' animal-free solutions can significantly improve efficiency."

Apple MacBook Air is a trademark of Apple, Inc.

About Novozymes
Novozymes ( is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources.

With over 700 products used in 130 countries, Novozymes' bioinnovations improve industrial performance and safeguard the world's resources by offering superior and sustainable solutions for tomorrow's ever-changing marketplace.

Novozymes' natural solutions enhance and promote everything from removing trans-fats in food, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature's potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces.

Our 5,000+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow.

Novozymes Biopharma:
Sally Vernon, Marketing Communications Manager
T: +44 115 955 3355
E: syke[.]

Corporate Contacts:
Press and media:
Johan Melchior
T: +45 4446 0690
M: +45 3077 0690
René Tronborg
T: +45 4446 2274
M: +45 3077 2274
Paige Donnelly (USA)
T: +1 919 494 3209
M: +1 919 218 4501

Investor relations:
Camilla Kinch Jensen
T: +45 4446 0852
M: +45 3077 0852
Tobias Bjørklund (USA)
T: +1 919 494 3483
M: +1 919 649 2565

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: The Scott Partnership


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Novozymes Biopharma Unveils New Online Customer Experience

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Fiona Robinson 
+44 1477 539539 pr[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From The Scott Partnership / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  MagLar, Inc.


  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (